Circulating miRNAs as Promising Biomarkers to Evaluate ECMO Treatment Responses in ARDS Patients
The use of extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome (ARDS) has increased in the last decade. However, mortality remains high, and the complexity of ECMO requires individualized treatment. There are some biomarkers to monitor progression and predict clinical...
Main Authors: | Gennaro Martucci, Antonio Arcadipane, Fabio Tuzzolino, Giovanna Occhipinti, Giovanna Panarello, Claudia Carcione, Alessandro Bertani, Pier Giulio Conaldi, Vitale Miceli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Membranes |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0375/11/8/551 |
Similar Items
-
Identification of a Circulating miRNA Signature to Stratify Acute Respiratory Distress Syndrome Patients
by: Gennaro Martucci, et al.
Published: (2021-12-01) -
Ecmo in a diabetic patient with cerebellar infarction and ARDS- A case report
by: elham asadpour, et al.
Published: (2019-12-01) -
Ecmo in a diabetic patient with cerebellar infarction and ARDS-A case report
by: Reza Nikandish, et al.
Published: (2019-12-01) -
Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
by: Stefanie Prohaska, et al.
Published: (2018-02-01) -
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
by: Benjamin Friedrichson, et al.
Published: (2021-01-01)